Literature DB >> 23986389

Design and synthesis of the stabilized analogs of belactosin A with the unnatural cis-cyclopropane structure.

Shuhei Kawamura1, Yuka Unno, Akira Asai, Mitsuhiro Arisawa, Satoshi Shuto.   

Abstract

The belactosin A analog 2a, having the unnatural cis-cyclopropane structure instead of the trans-cyclopropane structure in belactosin A, is a much more potent proteasome inhibitor than belactosin A. However, its cell growth inhibitory effect is rather lower than that expected from its remarkable proteasome inhibitory effect, probably due to its instability under cellular conditions. We hypothesized that the instability of 2a was due to chemical and enzymatic hydrolysis of the strained β-lactone moiety. Thus, to increase the stability of 2a by chemical modification, its analogs with a sterically more hindered β-lactone moiety and/or cyclopropylic strain-based conformational restriction were designed and synthesized, resulting in the identification of a stabilized analog 6a as a proteasome inhibitor with cell growth inhibitory effects. Our findings suggest that the chemical and biological stability of 2a is significantly affected by the steric hindrance around its β-lactone carbonyl moiety and the conformational flexibility of the molecule.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986389     DOI: 10.1039/c3ob41338a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

Authors:  Mingzhao Zhu; Wayne D Harshbarger; Omar Robles; Joanna Krysiak; Kenneth G Hull; Sung Wook Cho; Robyn D Richardson; Yanyan Yang; Andres Garcia; Lindsey Spiegelman; Bianca Ramirez; Christopher T Wilson; Ju Anne Yau; James T Moore; Caitlen B Walker; James C Sacchettini; Wenshe R Liu; Stephan A Sieber; Jeffrey W Smith; Daniel Romo
Journal:  Bioorg Med Chem       Date:  2017-01-19       Impact factor: 3.641

2.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

3.  Cystargolide-based amide and ester Pz analogues as proteasome inhibitors and anti-cancer agents.

Authors:  Carlos R Viera; Bradley T Stevens; Talysa Viera; Cameron Zielinski; Lee A Uranga; Snezna Rogelj; Praveen L Patidar; Rodolfo Tello-Aburto
Journal:  R Soc Open Sci       Date:  2022-09-28       Impact factor: 3.653

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.